ICPAX
Price
$9.11
Change
-$0.02 (-0.22%)
Updated
Aug 21 closing price
Net Assets
203.45M
VENAX
Price
$89.68
Change
-$0.06 (-0.07%)
Updated
Aug 21 closing price
Net Assets
12.38B
Interact to see
Advertisement

ICPAX vs VENAX

ICPAX vs VENAX Comparison Chart in %
View a ticker or compare two or three
VS
ICPAX vs. VENAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICPAX is a Hold and VENAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VENAX has more cash in the bank: 12.4B vs. ICPAX (203M). VENAX pays higher dividends than ICPAX: VENAX (2.40) vs ICPAX (0.22). ICPAX was incepted earlier than VENAX: ICPAX (27 years) vs VENAX (22 years). ICPAX (1.50) is less costly to investors than VENAX (0.09). ICPAX is a more actively managed with annual turnover of: 63.34 vs. VENAX (11.00). ICPAX has a lower initial minimum investment than VENAX: ICPAX (1000) vs VENAX (100000). VENAX annual gain was more profitable for investors over the last year : 48.08 vs. ICPAX (42.07). VENAX (181.39) and ICPAX (174.19) have equivalent 5 years return.
ICPAXVENAXICPAX / VENAX
Total Expense Ratio1.500.091,667%
Annual Report Gross Expense Ratio1.500.091,667%
Fund Existence27 years22 years-
Gain YTD32.07042.55375%
Front Load5%N/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets203M12.4B2%
Annual Yield % from dividends0.222.409%
Returns for 1 year42.0748.0887%
Returns for 3 years78.9746.44170%
Returns for 5 years174.19181.3996%
Returns for 10 years91.7985.74107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACMIX12.810.08
+0.63%
Absolute Capital Defender Institutional
UBVFX90.920.56
+0.62%
Undiscovered Managers Behavioral Val R6
DDDRX17.300.04
+0.21%
Nomura Wealth Builder R
SWASX7.26N/A
N/A
Schwab Global Real Estate
FSCRX26.55N/A
N/A
Fidelity Small Cap Discovery